Volume 66, Issue 3, Pages (September 2014)

Slides:

Advertisements

Similar presentations

Volume 61, Issue 5, Pages (May 2012)

Advertisements

Volume 62, Issue 4, Pages (October 2012)

The PSA Era is not Over for Prostate Cancer

Volume 64, Issue 3, Pages (September 2013)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer Marisa Warmuth,

The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks Marcus G.

Volume 60, Issue 5, Pages (November 2011)

Volume 70, Issue 1, Pages (July 2016)

Volume 60, Issue 5, Pages (November 2011)

Volume 72, Issue 5, Pages (November 2017)

Volume 67, Issue 4, Pages (April 2015)

Volume 63, Issue 1, Pages (January 2013)

Volume 53, Issue 5, Pages (May 2008)

Volume 69, Issue 1, Pages (January 2016)

Volume 51, Issue 4, Pages (April 2007)

Volume 73, Issue 1, Pages (January 2018)

Volume 66, Issue 6, Pages (December 2014)

Prostate Cancer Epidemic in Sight?

The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow chart summarising the process for the identification of eligible studies.

Volume 65, Issue 6, Pages (June 2014)

John P. Mulhall, Francesco Montorsi European Urology

Volume 63, Issue 4, Pages e53-e56 (April 2013)

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 68, Issue 4, Pages (October 2015)

Volume 54, Issue 4, Pages (October 2008)

The Potential of MicroRNAs as Prostate Cancer Biomarkers

Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka

Volume 70, Issue 3, Pages (September 2016)

Long-Term Management of Overactive Bladder with Antimuscarinic Agents

Prostate Cancer Detection: A View of the Future

Volume 68, Issue 3, Pages (September 2015)

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 69, Issue 4, Pages (April 2016)

Volume 64, Issue 3, Pages (September 2013)

Volume 57, Issue 4, Pages e41-e42 (April 2010)

Counselling the Prostate Cancer Patient

Volume 54, Issue 2, Pages (August 2008)

Prostate Cancer Epidemic in Sight?

The PSA Era is not Over for Prostate Cancer

Volume 71, Issue 4, Pages (April 2017)

Volume 61, Issue 5, Pages (May 2012)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Volume 68, Issue 6, Pages (December 2015)

Prostate-Specific Antigen Kinetics and Outcomes in Patients with Bone Metastases from Castration-Resistant Prostate Cancer Treated with or Without Zoledronic.

Volume 62, Issue 6, Pages (December 2012)

Volume 72, Issue 6, Pages (December 2017)

Volume 50, Issue 5, Pages (November 2006)

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Volume 55, Issue 3, Pages (March 2009)

Volume 74, Issue 6, Pages (December 2018)

Transurethral Resection of the Prostate

Volume 71, Issue 5, Pages (May 2017)

Volume 73, Issue 2, Pages (February 2018)

Jacques Irani European Urology Supplements

The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.

Volume 72, Issue 5, Pages (November 2017)

European Urology is “Your” Journal

Jonathan S. Brajtbord, Michael S. Leapman, Matthew R. Cooperberg

Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature Liliana Vartolomei, Shahrokh F. Shariat, Mihai.

Is long-term physical activity safe for older adults with knee pain

A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study John Fitzpatrick European.

Videolaryngoscopy versus direct laryngoscopy for adult patients requiring tracheal intubation: a Cochrane Systematic Review† S.R. Lewis, A.R. Butler,

Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.

The Comparability of Models for Predicting the Risk of a Positive Prostate Biopsy with Prostate-Specific Antigen Alone: A Systematic Review Fritz Schröder,

Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson

Systematic Review of Complications of Prostate Biopsy

New Research Findings on Clinical Benefits of Bisphosphonates in Patients With Advanced Prostate Cancer Noel W. Clarke European Urology Supplements

Presentation transcript:

Volume 66, Issue 3, Pages 416-427 (September 2014) Patient-reported Outcomes in Randomised Controlled Trials of Prostate Cancer: Methodological Quality and Impact on Clinical Decision Making Fabio Efficace, Michael Feuerstein, Peter Fayers, Valentina Cafaro, James Eastham, Andrea Pusic, Jane Blazeby European Urology Volume 66, Issue 3, Pages 416-427 (September 2014) DOI: 10.1016/j.eururo.2013.10.017 Copyright © 2013 Terms and Conditions

Fig. 1 Schematic breakdown of literature search results of Prostate Randomised Controlled Trials (Preferred Reporting Items for Systematic Reviews and Meta-analysis). PRO=patient-reported outcomes. European Urology 2014 66, 416-427DOI: (10.1016/j.eururo.2013.10.017) Copyright © 2013 Terms and Conditions

Fig. 2 Descriptive comparison of the level of reporting on selected key patient-reported outcomes issues in randomised controlled trials of prostate cancer by year of publication. RCT=randomised controlled trial. * This percentage is calculated by considering all studies reviewed (including those mentioning an exploratory evaluation); data from RCTs published between 1980 and 2001 were extracted from Efficace et al. [7]. † A statistically significant difference of p<0.05. European Urology 2014 66, 416-427DOI: (10.1016/j.eururo.2013.10.017) Copyright © 2013 Terms and Conditions

Fig. 3 Bar chart showing the risk of bias across randomised controlled trials by quality of patient-reported outcomes studies. PRO=patient-reported outcomes. European Urology 2014 66, 416-427DOI: (10.1016/j.eururo.2013.10.017) Copyright © 2013 Terms and Conditions